Despite this, the functionality of these T cells is inhibited by the PD-1/PD-L1 axis (PD-L1 expressed by tumor cells) and CTLA-4 signaling (expressed by T cells), alongside immune suppressors within the microenvironment (41, 43). The gene discussed is CTLA4; the disease is neoplasm.